ACTN1 and gastric cancer: Then the EDU incorporation, the assay revealing the proliferation ability of cells, showed that knocking down ACTN1 significantly reduced the proliferation ability of gastric cancer cells, while the overexpression enhanced the proliferation ability (Figure 3d).